Search Results for time in range

...://www.diabetesjournals.org/journals/pages/license . Glycemic status is assessed by A1C measurement, blood glucose monitoring (BGM) by capillary (finger-stick) devices, and continuous glucose monitoring (CGM) using time in range (TIR) or mean CGM glucose. Clinical trials of interventions that lower A1C have...

... by type 1 diabetes by showing a mild improvement in A1C and a significant improvement in the maternal glucose time in range (TIR), without an increase in hypoglycemia, and reductions in large-for-gestational-age births, length of infant hospital stays, and severe neonatal hypoglycemia (49...

...), and basal insulin (72 , 81) have consistently shown reductions in A1C levels and increases in time in range (TIR) (70–180 mg/dL [3.9–10 mmol/L]) but not a reduction in rates of hypoglycemia. The improvements in type 2 diabetes have largely occurred without changes in insulin doses or other diabetes...

..., and after exercise, with or without continuous glucose monitoring (CGM), maximize safety with exercise. The use of AID systems may improve time in range (TIR) (70–180 mg/dL) during exercise, and youth can use brand-specific settings that are more conservative or increase the glycemic goal to prevent...

... (adjusted treatment difference −1.9% [−27 min/day]; 95% CI −2.8% to −1.1% [−40 to −16 min/day]; P < 0.001) (38 , 39). Among secondary outcomes, time spent in range between 70 and 180 mg/dL increased by 8% (95% CI 6.0–11.5) and glycemic variability (%CV) decreased. A 6-month extension...

... of the cardiovascular composite (cardiovascular death or hospitalization for heart failure), and time to death from any cause. The trial had 4,304 participants with a mean eGFR at baseline of 43.1 ± 12.4 mL/min/1.73 m² (range 25–75 mL/min/1.73 m^{2) and a median UACR of 949 mg/g (range 200–5,000 mg/g}...

... diabetes mellitus (GDM). Language was also added to clarify the international consensus on time in range for pregnant individuals with type 2 diabetes or GDM. Recommendation 15.15 was updated to clarify that metformin and glyburide, individually or in combination, should not be used as first-line...

... while reducing the risk of hypoglycemia (26 – 31). Data are emerging on the safety and effectiveness of do-it-yourself systems (32 , 33). Evidence suggests that an AID hybrid closed-loop system is superior to AID sensor-augmented pump therapy for increased percentage of time in range and reduction...

... crisis, a random plasma glucose ≥200 mg/dL (≥11.1 mmol/L). Random is any time of the day without regard to time since previous meal. DCCT, Diabetes Control and Complications Trial; FPG, fasting plasma glucose; OGTT, oral glucose tolerance test; NGSP, National Glycohemoglobin Standardization Program...

... glycemic management. Ongoing diabetes self-management education and support are critical to empowering people, preventing acute complications, and reducing the risk of long-term complications. Significant evidence exists that supports a range of interventions to improve diabetes outcomes. The American...

... glycemic outcomes in the hospital found significant improvement in the percentage of time individuals spent in the glycemic goal range, lower mean blood glucose levels, and no increase in hypoglycemia (13). Where feasible, there should be structured order sets that provide computerized guidance...

... with CGM alone (64 , 65). Similarly, DSMES plus intermittently scanned CGM has demonstrated increased time in range (70–180 mg/dL [3.9–10.0 mmol/L]), less time above range, and a greater reduction in A1C compared with DSMES alone (66). Incorporating a systematic approach for technology assessment, adoption...

... commonly 1–3 h after a high-carbohydrate meal. Symptoms range from sweating, tremor, tachycardia, and increased hunger to impaired cognition, loss of consciousness, and seizures. In contrast to dumping syndrome, which often occurs soon after surgery and improves over time, post–bariatric surgery...

... People with type 2 diabetes should have an initial dilated and comprehensive eye examination by an ophthalmologist or optometrist at the time of the diabetes diagnosis. B 12.5 If there is no evidence of retinopathy from one or more annual eye exams and glycemic indicators are within the goal range...

... to lifestyle therapy, have prompt initiation and timely titration of two drugs or a single-pill combination of drugs demonstrated to reduce cardiovascular events in people with diabetes. A 10.9 Treatment for hypertension should include drug classes demonstrated to reduce cardiovascular events in people...

...  • Assessment for NAFLD/NASH Goal setting  • Set A1C/blood glucose/time in range  • If hypertension is present, establish blood pressure goal  • Weight management and physical activity goals  • Diabetes self-management goals Therapeutic treatment plans  • Lifestyle management...

... ( Table 2.1 ) (see Section 2, “ Diagnosis and Classification of Diabetes ”). Testing high-risk adults for prediabetes is warranted because the laboratory assessment is safe and reasonable in cost, substantial time exists before the development of type 2 diabetes and its complications during which one can...

.../journals/pages/license . 1.1 Ensure treatment decisions are timely, rely on evidence-based guidelines, capture key elements within the social determinants of health, and are made collaboratively with people with diabetes and care partners based on individual preferences, prognoses...